Search - tctmd.com

Displaying 181 - 200 of 638

Sort: Relevancy | Date

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

SCAI Updates Position on Doing PCI Without Surgical Backup

Michael O'Riordan

February 20, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Todd Neale

January 06, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Todd Neale

November 17, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Daily News

Drop in Kawasaki Disease During COVID-19 Provides Clues to Pathogenesis

Todd Neale

October 21, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News EACTS 2022

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Shelley Wood

October 12, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Presenter: Yeonwoo Choi

September 19, 2022

Presentation TCT 2022

Using AI-Based Analysis of ECGs and Multimodality Datasets to Improve Diagnosis of Valvular Heart Disease, Cardiac Amyloidosis, and Heart Failure

Presenter: Timothy Joseph Poterucha

September 19, 2022

Advertisement

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

SCAI Updates Position on Doing PCI Without Surgical Backup

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Top Structural Heart News of 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Drop in Kawasaki Disease During COVID-19 Provides Clues to Pathogenesis

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Using AI-Based Analysis of ECGs and Multimodality Datasets to Improve Diagnosis of Valvular Heart Disease, Cardiac Amyloidosis, and Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content